These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 11212158

  • 1. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
    Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H.
    Arthritis Rheum; 2001 Jan; 44(1):180-5. PubMed ID: 11212158
    [Abstract] [Full Text] [Related]

  • 2. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 3. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 4. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S, Robbins J, West CR, Nemeth MA.
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [Abstract] [Full Text] [Related]

  • 5. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
    Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J.
    Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
    [Abstract] [Full Text] [Related]

  • 6. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.
    Ta LE, Dionne RA.
    Pain; 2004 Sep; 111(1-2):13-21. PubMed ID: 15327804
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
    Emkey R, Rosenthal N, Wu SC, Jordan D, Kamin M, CAPSS-114 Study Group.
    J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
    [Abstract] [Full Text] [Related]

  • 8. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A, Williams GW, McKenna F, Fort JG.
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [Abstract] [Full Text] [Related]

  • 9. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS.
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ, Espinoza LR, Sherrer YR, Liu-Dumaw M, West CR.
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [Abstract] [Full Text] [Related]

  • 11. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.
    Wanders A, Heijde Dv, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M.
    Arthritis Rheum; 2005 Jun; 52(6):1756-65. PubMed ID: 15934081
    [Abstract] [Full Text] [Related]

  • 12. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J, Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group.
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [Abstract] [Full Text] [Related]

  • 14. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG, Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators.
    Arch Intern Med; 2005 Jan 24; 165(2):161-8. PubMed ID: 15668361
    [Abstract] [Full Text] [Related]

  • 15. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R, Krishnaswami S, Kowalski K.
    Clin Ther; 2007 Jan 24; 29 Suppl():2498-510. PubMed ID: 18164917
    [Abstract] [Full Text] [Related]

  • 16. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
    Petri M, Hufman SL, Waser G, Cui H, Snabes MC, Verburg KM.
    J Rheumatol; 2004 Aug 24; 31(8):1614-20. PubMed ID: 15290743
    [Abstract] [Full Text] [Related]

  • 17. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B, Godio L, Patterson S, Rodriguez-Bigas MA, Jester SL, King KL, Schumacher M, Abbruzzese J, DuBois RN, Hittelman WN, Zimmerman S, Sherman JW, Kelloff G.
    N Engl J Med; 2000 Jun 29; 342(26):1946-52. PubMed ID: 10874062
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS, Buvenandran A, Katz B, Kroin JS.
    Anesth Analg; 2008 Apr 29; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
    Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Golder W, Gromnica-Ihle E, Kellner H, Schneider M, Sörensen H, Zeidler H, Reddig J, Sieper J.
    Arthritis Rheum; 2003 Aug 29; 48(8):2224-33. PubMed ID: 12905476
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators.
    Am J Med; 2006 Mar 29; 119(3):255-66. PubMed ID: 16490472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.